News
Holodiag at CPhI Worldwide, Frankfurt, 24-26 October 2017
October 2017
Holodiag was present at CPhI Worldwide, held in Frankfurt, Germany, from October 24th to 26th 2017.
We were located on the PolePharma pavilion on the ICSE International Contract Services Expo, hall 4.1, stand # 41D50.
Holodiag celebrates 10th anniversary with increased R&D investments and new partnership
October 2017
Holodiag celebrates the company’s 10th anniversary and prepares to enter its second decade with a multitude of new R&D, marketing and strategic projects.
Since its creation in 2007, Holodiag has continuously made considerable investments in both specialised physico-chemical analytical equipment and R&D. Over the last couple of years, R&D services have become increasingly important and now take a prominent place in the company’s portfolio.
Holodiag and Holochem sign strategic partnership to offer integrated CMC services
September 2017
Holodiag, provider of Solid State solutions, and Holochem, provider of Chemical and Process development services, announce the signing of a strategic partnership, enabling both companies to supply their customers with a full range of integrated fine chemical and API Contract Development & Manufacturing services, through all stages of the drug development lifecycle.
Holodiag and Cobra launch LabCom project
March 2015
Pierric Marchand, C.E.O. and founder of Holodiag, and Vincent Levacher, CNRS Research Director, jointly created CrisOrg, a research laboratory dedicated to finding new ways to obtain pure enantiomers. The laboratory recently initiated the LabCom project, a R&D program that is co-financed by the ANR, the French organisation for the promotion and advance of scientific projects.